Biotecnología
Biotecnología
Antheia Receives $40 million in Venture Debt Financing
24/06/2022 -
Announces plans to construct a new pilot scale biomanufacturing facility.
BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa
24/06/2022 -
Facility will be initially equipped with two BioNTainers, and is expected to employ about 100 staff by 2024.
Cullinan Oncology, Taiho to Develop & Commercialize CLN-081/TAS6417 in the U.S.
24/06/2022 -
Will equally share future profits in the U.S.
Avantor, GeminiBio Partner on Custom Hydrated Solutions and Cell Culture Media
24/06/2022 -
Aims to support growth of emerging modalities by offering custom cGMP solutions to enhance process efficiency and accelerate time-to-market.
Galapagos to Acquire CellPoint and AboundBio
23/06/2022 -
Gains scalable, decentralized and automated point-of-care cell therapy supply model and next-gen fully human antibody-based therapeutics platform.
FDA Approves Merck’s Vaxneuvance in Infants and Children
23/06/2022 -
Becomes the first pneumococcal conjugate vaccine approved in almost a decade to help protect pediatric populations.
Sanofi
22/06/2022
Pfizer
22/06/2022
Novartis
22/06/2022
Top 25 Pharma and Biopharma Report
22/06/2022
ChargePoint Technology Expands in Europe
22/06/2022 -
New facility near Munich will support customers in the DACH region.
Waters and BioInfra Establish the ASEAN Academy for Bioanalysis
22/06/2022 -
Companies collaborate to promote development of bioanalytical skills with joint opening of the ASEAN Academy for Bioanalysis in South Korea.
OrganaBio Begins GMP Manufacturing Operations
22/06/2022 -
The cell therapy CDMO offers access to flexible manufacturing solutions and clinical grade cellular raw materials.
New Agreement Paves Way for Development of First African-owned COVID-19 Vaccine
22/06/2022 -
Afrigen and Univercells enter a new agreement to develop the first African-own COVID-19 vaccine.
Piramal Pharma Solutions Appoints Herve Berdou as Chief Operating Officer
22/06/2022 -
Brings 25 years of global operations and supply chain experience to the new role.
Pfizer to Invest $95 Million in Valneva
21/06/2022 -
Funds will further support the strategic Lyme partnership between the two companies.
OrganaBio Launches Contract Cell Therapy Manufacturing Ops
21/06/2022 -
To provide custom contract-, self-, and hybrid-manufacturing options for therapeutics developers.
Abbvie’s SKYRIZI FDA-Approved as First IL-23 to Treat Crohn's Disease
21/06/2022 -
As early as week 4, clinical response and clinical remission were achieved by significantly more subjects treated with SKYRIZI versus placebo.
Avid Bioservices and CRB Partner on Viral Vector Facility
21/06/2022 -
53,000-square-foot facility addresses demands of commercial-scale viral vector production.
BioCina Opens New GMP Plasmid DNA Manufacturing Suite
21/06/2022 -
Equipped with up to 300 L single use fermentation capacity and suitably scaled downstream processing equipment.
Batavia Biosciences Expands HQ and R&D Services
21/06/2022 -
Increases capacity for viral vectors and vaccine R&D in Netherlands.
